Artwork

Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Episode 507: LIVE from ILADS: Dr. Louis Teulières - Advancing Lyme Disease Diagnostics with Phage-Based Testing

16:51
 
Share
 

Manage episode 479119857 series 2540476
Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Key Takeaways:

  • Dr. Louis Teulières, a multi-national doctor with an MD and PhD, has been actively involved with ILADS since 2016 due to his research on bacteriophages at the University of Leicester.
  • Frustrated with the limitations of antibiotic treatments for Borrelia, the bacteria that causes Lyme disease, Dr. Teulières explored bacteriophages as a novel diagnostic and therapeutic approach.
  • Due to regulatory challenges in administering phage therapy, Dr. Teulières and his team developed a phage-based test that can directly detect the presence of Borrelia bacteria.
  • This test, marketed by Red Labs in Europe for the past four years, has been used on thousands of patients and can differentiate between early, late-stage, and post-treatment Lyme disease.
  • Dr. Teulières is now working to expand the test’s reach in the U.S., seeking partnerships with American clinicians and researchers to validate the test and pursue FDA clearance.
  • The discussion underscores the need for innovative diagnostic tools to improve Lyme disease detection and accelerate healing journeys for patients.

About Dr. Louis Teulières:

  • Medical degree from University of Nice, France.
  • Specializations in immunology, hematology, immunopathology, bacteriology, and epidemiology at the Pasteur Institute in Paris and CDC in Atlanta.
  • Former researcher at the Pasteur Institute, contributing to studies on immune and infectious diseases such as HIV.
  • Active member of the immunology team that received the Nobel Prize in 2008 for discovering the HIV virus in 1983.
  • Founder of CMIL clinics in Lisbon and Paris, specializing in immune and infectious diseases, Lyme disease, and neurodegenerative conditions.
  • Co-founder of PHELIX, a charity dedicated to phage-based research and diagnostics in Lyme disease.
  • Collaborates with University of Leicester, St Thomas Hospital in London, and other world-class healthcare professionals.

Resources & Links:

  continue reading

521 episodes

Artwork
iconShare
 
Manage episode 479119857 series 2540476
Content provided by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Matt Sabatello and Rich Johannesen, Matt Sabatello, and Rich Johannesen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Key Takeaways:

  • Dr. Louis Teulières, a multi-national doctor with an MD and PhD, has been actively involved with ILADS since 2016 due to his research on bacteriophages at the University of Leicester.
  • Frustrated with the limitations of antibiotic treatments for Borrelia, the bacteria that causes Lyme disease, Dr. Teulières explored bacteriophages as a novel diagnostic and therapeutic approach.
  • Due to regulatory challenges in administering phage therapy, Dr. Teulières and his team developed a phage-based test that can directly detect the presence of Borrelia bacteria.
  • This test, marketed by Red Labs in Europe for the past four years, has been used on thousands of patients and can differentiate between early, late-stage, and post-treatment Lyme disease.
  • Dr. Teulières is now working to expand the test’s reach in the U.S., seeking partnerships with American clinicians and researchers to validate the test and pursue FDA clearance.
  • The discussion underscores the need for innovative diagnostic tools to improve Lyme disease detection and accelerate healing journeys for patients.

About Dr. Louis Teulières:

  • Medical degree from University of Nice, France.
  • Specializations in immunology, hematology, immunopathology, bacteriology, and epidemiology at the Pasteur Institute in Paris and CDC in Atlanta.
  • Former researcher at the Pasteur Institute, contributing to studies on immune and infectious diseases such as HIV.
  • Active member of the immunology team that received the Nobel Prize in 2008 for discovering the HIV virus in 1983.
  • Founder of CMIL clinics in Lisbon and Paris, specializing in immune and infectious diseases, Lyme disease, and neurodegenerative conditions.
  • Co-founder of PHELIX, a charity dedicated to phage-based research and diagnostics in Lyme disease.
  • Collaborates with University of Leicester, St Thomas Hospital in London, and other world-class healthcare professionals.

Resources & Links:

  continue reading

521 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play